首页> 外国专利> Novel recombinant protein from bacteriophage having antibacterial activity to pathogenic gram-negative bacterium

Novel recombinant protein from bacteriophage having antibacterial activity to pathogenic gram-negative bacterium

机译:来自噬菌体的新型重组蛋白对致病性革兰氏阴性细菌具有抗菌活性

摘要

The present invention relates to a bacteriophage-derived recombinant protein having antimicrobial activity against Gram-negative bacteria, and the bacteriophage-derived recombinant protein LysSS of the present invention exhibits killing ability to Gram-negative bacteria and can prevent or treat infectious diseases caused by bacteria, antibiotics, It can be widely used in disinfectants, food additives, feed additives and the like. In particular, the LysSS exhibits bacterial killing ability due to peptidoglycan decomposition using peptidoglycan, which is a cell wall component of bacteria, as a substrate, and peptidoglycan exists only in bacteria and not in humans or animals. LysSS of the present invention is safe and does not affect humans and animals, and can be applied to the pharmaceutical industry, food industry, biotechnology, etc., and effectively kills gram-negative bacteria at a target place or a target substance without problems of multi-drug antimicrobial resistance. There is an advantage to this.
机译:本发明涉及对革兰氏阴性菌具有抗菌活性的噬菌体来源的重组蛋白,本发明的噬菌体来源的重组蛋白LysSS对革兰氏阴性菌具有杀伤能力,可以预防或治疗由细菌引起的感染性疾病。 ,抗生素,可广泛用于消毒剂,食品添加剂,饲料添加剂等中。特别地,由于使用作为细菌的细胞壁成分的肽聚糖作为底物的肽聚糖分解,LysSS显示出细菌杀伤能力,并且肽聚糖仅存在于细菌中而不存在于人或动物中。本发明的LysSS是安全的并且不影响人和动物,并且可以应用于制药工业,食品工业,生物技术等,并且可以有效地杀死目标部位或目标物质上的革兰氏阴性菌而没有问题。多药耐药性。这有一个好处。

著录项

  • 公开/公告号KR102068591B1

    专利类型

  • 公开/公告日2020-01-21

    原文格式PDF

  • 申请/专利权人 경북대학교 산학협력단;

    申请/专利号KR20180051191

  • 发明设计人 김정민;김석호;

    申请日2018-05-03

  • 分类号A61K38/16;A23K20/147;A23L33/18;A61K48;A61P31;C07K14/005;

  • 国家 KR

  • 入库时间 2022-08-21 11:05:32

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号